A 12-week TRE protocol (6h window) is being tested for early Huntington’s Disease, showing potential benefits for mitochondrial function and autophagy with 80% adherence expected. New clinical t...
Recent research reveals how intermittent fasting protocols interact with circadian rhythms to improve insulin sensitivity, gut microbiome diversity, and metabolic markers beyond weight loss. Emerging ...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
A 12-week clinical trial explores time-restricted eating’s effects on cognitive function and mitochondrial health in Huntington’s disease patients. New research investigates whether time-restr...
New clinical trial explores time-restricted eating’s potential benefits for Huntington’s disease patients, focusing on metabolic health and symptom management. A groundbreaking clinical tr...
Recent studies highlight the benefits of time-restricted eating for insulin sensitivity, weight loss, and reduced inflammation, with practical guidelines for implementation. Emerging research undersco...
A recent PLoS One study reveals that a 12-week time-restricted eating protocol improves mitochondrial function and reduces polyQ aggregation in Huntington’s disease patients. Groundbreaking rese...
New research demonstrates how 14:10 and 16:8 fasting windows improve blood pressure through dual mechanisms of endothelial function enhancement and gut microbiome modulation. Emerging evidence positio...
New research suggests time-restricted eating may improve mitochondrial function and reduce protein aggregates in early-stage Huntington’s disease patients. Emerging evidence indicates TRE may offer ...
A 12-week TRE intervention with 6-8h eating windows demonstrates potential benefits for HD patients by improving mitochondrial function and cognitive scores, though adherence challenges remain. Emergi...
